Antisense compounds, compositions and methods are provided for modulating
the expression of PLML. The compositions comprise antisense compounds,
particularly antisense oligonucleotides, targeted to nucleic acids
encoding PLML. Methods of using these compounds for modulation of PLML
expression and for treatment of diseases associated with expression of
PLML are provided.
